New supplement shows promise for heartburn relief in small trial
NCT ID NCT06889246
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 28 times
Summary
This study tested a health supplement called Anvitra in 27 adults with gastroesophageal reflux disease (GERD). Participants took the supplement for 14 days and were monitored for another week. The goal was to see if it reduces heartburn, regurgitation, and indigestion, and to check for any side effects. This is a small, early-stage study, so results are not conclusive.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERD (HEARTBURN, REGURGITATION, AND DYSPEPSIA) FREQUENCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Center for Clinical Trial and Bioequivalence Study
Haiphong, Hải Phòng, Vietnam
-
Center for Clinical Trial and Bioequivalence Study, Haiphong University of Medicine and Pharmacy
Haiphong, Vietnam
Conditions
Explore the condition pages connected to this study.